Denali Therapeutics Inc (DNLI)
Operating Income Growth
3.28%
Quarterly · Period ending:
DNLI Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported3.28%period ending
Latest reported3.28%period ending
DNLI Quarterly Operating Income YoY % (-18.42% → 3.28%)
Year-over-year change
High-resolution chart · PNG
DNLI operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 3.2765% | |
| 5.6484% | |
| -5.7907% | |
| -11.5653% | |
| -15.7557% | |
| -23.6716% | |
| 2.0562% | |
| -8.2534% | |
| -168.3898% | |
| 2.5659% | |
| -25.8467% | |
| -5.8696% | |
| 377.5873% | |
| -81.6822% | |
| -36.5957% | |
| -25.578% | |
| 0.6487% | |
| 6.6302% | |
| -131.5969% | |
| -42.3797% | |
| -0.8812% | |
| -18.7653% | |
| 522.5873% | |
| -19.8604% | |
| 2.3676% | |
| -41.0723% | |
| -177.2972% | |
| -32.112% | |
| -9.3775% | |
| -65.0924% | |
| 417.4257% | |
| -70.3338% | |
| -154.2627% | |
| -18.4143% | |
| -18.4939% | |
| 13.0462% | |
| -22.9027% | |
| -18.4152% |